To provide information to prescribers in Federally qualified health centers and facilities of the Indian Health Service on best practices for prescribing naloxone.

Bill: 114-hr-4983
Sponsor: full_name: Rep. Griffith, H. Morgan [R-VA-9]
Introduced: 2016-04-18
Policy area: Health
Subjects: Drug trafficking and controlled substances

Drug, alcohol, tobacco use

Health information and medical records

Health promotion and preventive care

Indian social and development programs

Minority health

Prescription drugs
Latest action: action_date: 2016-04-27
text: Referred to the Subcommittee on Indian, Insular and Alaska Native Affairs.

Summaries:
action_date: 2016-04-18
action_desc: Introduced in House
text: <p>This bill requires the Department of Health and Human Services to provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing naloxone (a prescription drug used to rapidly reverse an opioid overdose) for patients a provider identifies as having an elevated risk of opioid overdose. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)</p>

tv_txt: I 114th CONGRESS 2d Session H. R. 4983 IN THE HOUSE OF REPRESENTATIVES April 18, 2016 Mr. Griffith introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Natural Resources , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To provide information to prescribers in Federally qualified health centers and facilities of the Indian Health Service on best practices for prescribing naloxone.

1. Providing information to prescribers in certain Federal health care and medical facilities on best practices for prescribing Naloxone (a) In general Not later than 180 days after the date of enactment of this Act, the Secretary of Health and Human Services (in this section referred to as the Secretary ) shall, as appropriate, provide information to prescribers within Federally qualified health centers (as defined in paragraph (4) of section 1861(aa) of the Social Security Act ( 42 U.S.C. 1395x(aa) )), and the health care facilities of the Indian Health Service, on best practices for prescribing naloxone for patients receiving chronic opioid therapy, patients being treated for opioid use disorders, and other patients that a provider identifies as having an elevated risk of overdose from heroin or prescription opioid therapies. (b) Not establishing a medical standard of care The information on best practices provided under this section shall not be construed as constituting or establishing a medical standard of care for prescribing naloxone for patients described in subsection (a). (c) No authorization of any additional appropriations The Secretary shall carry out this section through funds otherwise appropriated and nothing in this section shall be construed as authorizing the appropriations of additional funds to carry out this section. (d) Elevated risk of overdose defined In this section, the term elevated risk of overdose has the meaning given such term by the Secretary, which— (1) may be based on the criteria provided in the Opioid Overdose Toolkit published by the Substance Abuse and Mental Health Services Administration (SAMHSA); and (2) may include patients on a first course opioid treatment, patients using extended-release and long-acting opioid analgesic, and patients with a respiratory disease or other comorbidities.